Treatment of Bacterial Vaginosis With Oral Tinidazole

Mission Pharmacal200 enrolled

Overview

The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.

Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to placebo to treat bacterial vaginosis, one of the most common vaginal infections.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

200

Conditions

Bacterial Vaginosis

Interventions

TinidazoleDRUG

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Clinical and microbiological diagnosis of bacterial vaginosis - Exclusion Criteria: Other sexually transmitted disease \-

Locations (1)

Duke University School of Medicine

Durham, North Carolina, United States

Outcomes

Primary Outcomes

Therapeutic efficacy

Safety

Secondary Outcomes

Clinical efficacy

Microbiological efficacy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.